Reliance Chemotex Industries Limited carries a market capitalization of 905.23M, placing it among publicly traded companies globally. Its enterprise value stands at 1.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 905.23M |
| Enterprise Value | 1.01B |
Reliance Chemotex Industries Limited trades at a trailing price-to-earnings ratio of 18.80.
| PE Ratio | 18.80 |
| PS Ratio | 0.29 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Reliance Chemotex Industries Limited trades at an EV/EBITDA multiple of 3.27 and an EV/FCF ratio of 6.47. The EV/Sales ratio of 0.29 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.27 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.29 |
| EV / EBITDA | 3.27 |
| EV / EBIT | 3.27 |
| EV / FCF | 6.47 |
Reliance Chemotex Industries Limited maintains a current ratio of 1.85, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 371.69, indicating elevated leverage, while an interest coverage ratio of 1.73 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.85 |
| Quick Ratio | 0.19 |
| Debt / Equity | 371.69 |
| Debt / EBITDA | N/A |
| Interest Coverage | 1.73 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 5.02 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Reliance Chemotex Industries Limited has paid 7.75M in income taxes, reflecting an effective tax rate of 12.64.
| Income Tax | 7.75M |
| Effective Tax Rate | 12.64 |
Reliance Chemotex Industries Limited's stock has declined approximately -37.40219% over the past 52 weeks. The 50-day moving average sits at 118.43, while the 200-day moving average is 136.76.
| Beta (5Y) | N/A |
| 52-Week Price Change | -37.40219% |
| 50-Day Moving Average | 118.43 |
| 200-Day Moving Average | 136.76 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Reliance Chemotex Industries Limited generated 3.48B in revenue and converted that into 53.56M in net income, yielding earnings per share of 7.10. EBITDA reached 307.53M, while operating income came in at 307.53M.
| Revenue | 3.48B |
| Gross Profit | 1.46B |
| Operating Income | 307.53M |
| Pretax Income | 61.31M |
| Net Income | 53.56M |
| EBITDA | 307.53M |
| EBIT | 307.53M |
| Earnings Per Share (EPS) | 7.10 |
Reliance Chemotex Industries Limited operates with a gross margin of 41.98, reflecting its pricing power and cost economics. The operating margin of 8.83 and net profit margin of 1.54 provide insight into operational efficiency.
| Gross Margin | 41.98 |
| Operating Margin | 8.83 |
| Pretax Margin | 1.76 |
| Profit Margin | 1.54 |
| EBITDA Margin | 8.83 |
Reliance Chemotex Industries Limited posts an Altman Z-Score of 2.27, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.27 |